MicroRNAs in Endothelial Senescence and Atherosclerosis
暂无分享,去创建一个
[1] S. Menini,et al. Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay , 2013, EMBO molecular medicine.
[2] P. Cossart,et al. Selective autophagy degrades DICER and AGO2 and regulates miRNA activity , 2012, Nature Cell Biology.
[3] F. Kiessling,et al. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. , 2012, The Journal of clinical investigation.
[4] J. Chiu,et al. Roles of microRNAs in atherosclerosis and restenosis , 2012, Journal of Biomedical Science.
[5] A. Thorburn,et al. Translational evidence that impaired autophagy contributes to arterial ageing , 2012, The Journal of physiology.
[6] P. Fasanaro,et al. MicroRNA Dysregulation in Diabetic Ischemic Heart Failure Patients , 2012, Diabetes.
[7] P. Davies,et al. Site-Specific MicroRNA-92a Regulation of Krüppel-Like Factors 4 and 2 in Atherosusceptible Endothelium , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[8] Ying Zhou,et al. [The influence of statin therapy on circulating microRNA-92a expression in patients with coronary heart disease]. , 2012, Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue.
[9] S. Menini,et al. TIMP3 Overexpression in Macrophages Protects From Insulin Resistance, Adipose Inflammation, and Nonalcoholic Fatty Liver Disease in Mice , 2012, Diabetes.
[10] S. Menini,et al. Overexpression of Tissue Inhibitor of Metalloproteinase 3 in Macrophages Reduces Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[11] P. Gentileschi,et al. Decreased IRS2 and TIMP3 Expression in Monocytes From Offspring of Type 2 Diabetic Patients Is Correlated With Insulin Resistance and Increased Intima-Media Thickness , 2011, Diabetes.
[12] T. Lehtimäki,et al. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. , 2011, Atherosclerosis.
[13] C. Weber,et al. Atherosclerosis: current pathogenesis and therapeutic options , 2011, Nature Medicine.
[14] R. Knight,et al. miR-146a is modulated in human endothelial cell with aging. , 2011, Atherosclerosis.
[15] Jing Yuan,et al. The altered expression of inflammation-related microRNAs with microRNA-155 expression correlates with Th17 differentiation in patients with acute coronary syndrome , 2011, Cellular and Molecular Immunology.
[16] S. Subramaniam,et al. MicroRNA-21 targets peroxisome proliferators-activated receptor-α in an autoregulatory loop to modulate flow-induced endothelial inflammation , 2011, Proceedings of the National Academy of Sciences.
[17] M. Gorospe,et al. MicroRegulators come of age in senescence. , 2011, Trends in genetics : TIG.
[18] J. Rakic,et al. MicroRNA-21 Exhibits Antiangiogenic Function by Targeting RhoB Expression in Endothelial Cells , 2011, PloS one.
[19] M. Kutryk,et al. Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease. , 2011, Biochemical and biophysical research communications.
[20] M. Guan,et al. Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. , 2011, Clinica chimica acta; international journal of clinical chemistry.
[21] M. Satoh,et al. Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels. , 2010, Clinical science.
[22] M. Mayr,et al. Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes , 2010, Circulation research.
[23] Stefanie Dimmeler,et al. Circulating MicroRNAs in Patients With Coronary Artery Disease , 2010, Circulation research.
[24] M. Yamakuchi,et al. MicroRNA-34a regulation of endothelial senescence. , 2010, Biochemical and biophysical research communications.
[25] Wei Zhou,et al. miR‐146a in PBMCs modulates Th1 function in patients with acute coronary syndrome , 2010, Immunology and cell biology.
[26] Jian Li,et al. MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. , 2010, American journal of physiology. Endocrinology and metabolism.
[27] M. Hristov,et al. Delivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection , 2009, Science Signaling.
[28] G. Melino,et al. MicroRNA 217 Modulates Endothelial Cell Senescence via Silent Information Regulator 1 , 2009, Circulation.
[29] M. Federici,et al. TIMP3 Is Reduced in Atherosclerotic Plaques From Subjects With Type 2 Diabetes and Increased by SirT1 , 2009, Diabetes.
[30] Stefanie Dimmeler,et al. MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice , 2009, Science.
[31] S. Menini,et al. Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice. , 2009, Gastroenterology.
[32] William Kong,et al. Strategies for profiling MicroRNA expression , 2009, Journal of cellular physiology.
[33] Lianbo Yu,et al. Detection of microRNA Expression in Human Peripheral Blood Microvesicles , 2008, PloS one.
[34] A. L. Fridman,et al. Critical pathways in cellular senescence and immortalization revealed by gene expression profiling , 2008, Oncogene.
[35] John McAnally,et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. , 2008, Developmental cell.
[36] Nicholas E. Bruns,et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy , 2008, Proceedings of the National Academy of Sciences.
[37] Joshua T. Mendell,et al. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1 , 2008, Proceedings of the National Academy of Sciences.
[38] J. Steitz,et al. Switching from Repression to Activation: MicroRNAs Can Up-Regulate Translation , 2007, Science.
[39] Cuk-Seong Kim,et al. SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase , 2007, Proceedings of the National Academy of Sciences.
[40] Stefanie Dimmeler,et al. Role of Dicer and Drosha for Endothelial MicroRNA Expression and Angiogenesis , 2007, Circulation research.
[41] Chunxiang Zhang,et al. MicroRNA Expression Signature and Antisense-Mediated Depletion Reveal an Essential Role of MicroRNA in Vascular Neointimal Lesion Formation , 2007, Circulation research.
[42] S. Vatner,et al. Sirt1 Regulates Aging and Resistance to Oxidative Stress in the Heart , 2007, Circulation research.
[43] Jordan S. Pober,et al. Dicer Dependent MicroRNAs Regulate Gene Expression and Functions in Human Endothelial Cells , 2007, Circulation research.
[44] I. Komuro,et al. Vascular Cell Senescence: Contribution to Atherosclerosis , 2007, Circulation research.
[45] L. Guarente,et al. Mammalian sirtuins--emerging roles in physiology, aging, and calorie restriction. , 2006, Genes & development.
[46] M. Stoffel,et al. MicroRNAs: a new class of regulatory genes affecting metabolism. , 2006, Cell metabolism.
[47] Jan Krützfeldt,et al. Strategies to determine the biological function of microRNAs , 2006, Nature Genetics.
[48] D. Accili,et al. Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha. , 2005, The Journal of clinical investigation.
[49] V. Kim. MicroRNA biogenesis: coordinated cropping and dicing , 2005, Nature Reviews Molecular Cell Biology.
[50] P. Ganz,et al. Role of Endothelial Dysfunction in Atherosclerosis , 2004, Circulation.
[51] S. Nagueh,et al. Avoiding Papillary Muscle Infarction With Myocardial Contrast Echocardiographic Guidance of Nonsurgical Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy , 2004 .
[52] S. Minucci,et al. Human SIR2 deacetylates p53 and antagonizes PML/p53‐induced cellular senescence , 2002, The EMBO journal.
[53] I. Komuro,et al. Endothelial Cell Senescence in Human Atherosclerosis: Role of Telomere in Endothelial Dysfunction , 2002, Circulation.
[54] Malcolm A. Latorre,et al. Bioengineered corneas for transplantation and in vitro toxicology. , 2009, Frontiers in bioscience.